Detalhe da pesquisa
1.
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(6): 646-657, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182538
2.
An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer.
Oncologist
; 28(12): e1160-e1169, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279952
3.
The investigation of circRNA profiling reveals the regulatory role of the hsa_circ_0000375/miR-7706 pathway in breast cancer.
Mol Biol Rep
; 50(12): 9993-10004, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904009
4.
Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting.
Cell Mol Biol (Noisy-le-grand)
; 69(8): 78-83, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715420
5.
GLIS Family Zinc Finger 3 Promotes Triple-Negative Breast Cancer Progression by Inducing Cell Proliferation, Migration and Invasion, and Activating the NF-κB Signaling Pathway.
Biol Pharm Bull
; 46(2): 209-218, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724950
6.
Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis.
J Mammary Gland Biol Neoplasia
; 27(1): 37-52, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239064
7.
Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 & SATB1 in HER-2-Positive breast cancer patients.
Pak J Med Sci
; 38(3Part-I): 553-559, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35480523
8.
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(3): 351-360, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581774
9.
Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay.
Int J Cancer
; 149(10): 1801-1808, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224580
10.
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
BMC Cancer
; 21(1): 341, 2021 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789616
11.
Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study.
Jpn J Clin Oncol
; 51(3): 345-353, 2021 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619550
12.
Recognition of the organ-specific mutations in metastatic breast cancer by circulating tumor cells isolated in vivo.
Neoplasma
; 68(1): 31-39, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940042
13.
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis.
Chin J Cancer Res
; 33(2): 243-255, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158743
14.
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
Cancer
; 126 Suppl 16: 3867-3882, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710660
15.
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.
Oncologist
; 25(10): e1473-e1480, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333626
16.
Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).
Qual Life Res
; 29(11): 3009-3015, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564293
17.
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(6): 806-815, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036468
18.
Association of PTPN1 polymorphisms with breast cancer risk: A case-control study in Chinese females.
J Cell Biochem
; 120(7): 12039-12050, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805963
19.
The Effect of the Leptin and Leptin Receptor Expression on the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer.
Med Sci Monit
; 25: 3005-3013, 2019 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015393
20.
Comparison of surgical complication between immediate implant and autologous breast reconstruction after mastectomy: A multicenter study of 426 cases.
J Surg Oncol
; 118(6): 953-958, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30261115